Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.
about
Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndromeIschemia-modified albumin measured with ultra-filtration assay in early diagnosis of acute coronary syndrome.The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma.Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort studyEnergy metabolism disorder and myocardial injury in chronic myocardial ischemia with Qi deficiency and blood stasis syndrome based on 2-DE proteomics.Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromesClinical significance of ischemia-modified albumin in the diagnosis of doxorubicin-induced myocardial injury in breast cancer patients.Ischemia modified albumin increase indicating cardiac damage after experimental subarachnoid hemorrhage.Ischaemia modified albumin: Does it bolster our diagnostic ammunition?Cardiac biomarkers in the intensive care unitBiomarkers of cardiac disease.Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.Ischemia modified albumin: A novel marker for acute coronary syndrome.Biological variation of ischaemia-modified albumin in healthy subjects.Proteomics and heart disease: identifying biomarkers of clinical utility.Present and future biochemical markers for detection of acute coronary syndrome.Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies.Diagnostic Utility of Neuregulin for Acute Coronary Syndrome.The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndromeUtility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department.The PRIMA study: presentation ischaemia-modified albumin in the emergency department.Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain.Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient.Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests.Biomarkers in Acute Coronary Syndrome.Diagnostic value of ischemia-modified albumin in acute coronary syndrome and acute ischemic stroke.Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma?Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathwaysIschemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.Current role of ischemia-modified albumin in routine clinical practice.Ischemia modified albumin changes - review and clinical implications.Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage.Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of "N-Terminal Modification" to "Fatty Acid Occupation" of Albumin.Serum ischaemia-modified albumin level is an irrelevant predictive factor for ischaemic duration in mesenteric ischaemia.Ischemia modified albumin: does it change during pneumoperitoneum in robotic prostatectomies?Proteomic analysis of rat plasma following transient focal cerebral ischemia.Ischemia-Modified Albumin and Atherosclerosis in Patients With Familial Mediterranean Fever.Novel application of flow propagation velocity and ischaemia-modified albumin in analysis of postexercise cardiac function in man.Cardiac markers in acute coronary syndrome.
P2860
Q33774564-8FBE93AE-3ADE-4718-84F0-CD4E4C603C82Q33853374-4DB59992-90C6-465B-A864-29493683BF3EQ34031976-BD95F769-A67A-498F-81BF-286AD352A26CQ34077810-43331D9B-E9F9-4AF4-BA1C-050B79CAB744Q34341643-26CF225A-E426-4F94-AD33-0D13E8FB3D63Q34501418-2CCD4C1F-59A9-45D7-BCB4-5605DC9AAF53Q35028692-CC4FB45E-B706-4493-BC82-F143AA870D12Q35041318-54155518-A4E2-4600-BAD3-FA388C908A1BQ35101732-99F4158E-5C90-4063-91A5-D36CEC774DC5Q35307480-52D88253-A55E-4CDE-AA91-C51B600FAE63Q35856435-D7C8F81F-D404-4C2B-8556-5C07F9C84FBAQ35938537-C991F914-462F-40EB-B918-93A3109C13AAQ36099107-C84B24E6-6BE5-42E4-81D4-E2E249151A43Q36264599-DFB5C0FF-F6F5-4FEF-825F-1A59EC74981DQ36294172-72C2D5D6-897E-4FC4-A1ED-31C4BF07AB0CQ36445586-E37B125E-1EAD-4111-BD35-C0B520CCDB59Q36624223-8BF33A75-5306-4538-AEE0-3C958073A7ECQ36645580-537C5938-DECE-4D4D-AEB1-B4FE53D4EA10Q36773401-D2B8DA6B-9651-46F2-82AF-69609404E515Q36924829-B073F675-64FA-4296-948A-EF3A93F708E6Q36964602-FB1C9928-5796-4E87-B783-0CCB96AB404AQ36964775-DF401BFE-7C25-4F4E-BDED-CB297F82BEE4Q37158173-733A0810-AFAB-4A51-8F06-C55B5051ADE5Q37192660-8874CE16-C32D-4395-9D8E-0C77F2D4BB5DQ37203592-363662F7-90FA-41CC-92DD-EE3C45BBD8E3Q37207294-75293A0B-965C-4345-9A37-9A7F751CE499Q37280372-710B8C2E-C925-428A-9D4C-AEC8D3C03499Q37359375-D11EF192-95D2-43AA-A837-9A560977F6BFQ37586770-E299B220-E57E-4FA9-93B6-CDD618D7CBCBQ37680427-D9092AF4-93EB-4F29-9219-77C65F09E6C5Q37793251-883BF3A9-4F4C-4BE9-863B-7A0C01391551Q37810261-FCED35CE-2AD4-491D-B2DA-199F99E9590BQ38172089-3F565237-5D9B-4F9C-93C3-D28DCB775879Q39207507-544EA8B0-A017-4682-8CAF-BCE9B53F04BEQ39351983-CFB284A5-E65C-400F-813B-6F3CA51572DBQ39620019-32197C0F-7020-4945-BB22-7D0AA8B3F7E3Q39684610-FE8A2A43-2C5D-49BA-837B-DF9A912B347FQ40144808-2758E568-28F5-4081-84D7-C3D2CC8CB741Q40356338-DE768973-A66F-4062-9DF6-65B2E4E430F0Q40409874-1FA9E20F-EE4B-4BFE-9412-82D550A46F7E
P2860
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@ast
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@en
type
label
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@ast
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@en
prefLabel
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@ast
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@en
P2093
P2860
P356
P1476
Role of "Ischemia modified alb ...... s of acute coronary syndromes.
@en
P2093
P2860
P356
10.1136/EMJ.2003.006007
P407
P577
2004-01-01T00:00:00Z